Semi-Annual Report — FY2026 H1
What GNI Group Ltd. reported for the period from 2026-01-01 to 2026-12-31.
Filed 2026-08-14View the original on EDINET
How much it says
63Detailed
What moved here
39named for the first time
Its own wording
44terms
Which filing this is
31/ 31newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim consolidated accounting period, sales of Eisuly remained solid in the pharmaceuticals business, and F351 advanced in China after its NDA was accepted and designated for priority review, while the medical devices business was affected by a decline in revenue despite the revenue contribution from ZOO LABO. Effective 1 July 2026, the company made あゆみ製薬ホールディングス a wholly owned subsidiary, while Gyre also made Cullgen a wholly owned subsidiary in the pharmaceuticals business. Temporary costs were incurred during this transition period of acquisitions and restructuring.
Komori's summary of this document, not the document's own words.63Detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
68
Detailed
90
Very detailed
62
Detailed
0
Almost nothing
53
Typical
71
Detailed
100
Very detailed
60
Detailed
55
Typical
50
Typical
R&D spend21億円Money spent making new things.
Cash left over-41億円Cash from the business, less what went into equipment.
Spent on equipment2億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.